The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
National News Cabinet Approves ₹14,115 Crore for Two Highway Projects The Union Cabinet has approved…
The Reserve Bank of India (RBI) has appointed Ravi Shankar as its new Executive Director…
Sunil Bharti Mittal, Founder and Chairman of Bharti Enterprises has been honored with the 2026…
The Government of India has extended the tenure of the current Foreign Secretary Vikram Misri…
From 1st of July, 2026, The Reserve Bank of India (RBI) has implemented the its…
Air Marshal Jasvir Singh Mann, AVSM, VSM appointed as the new Air Officer Commanding-in-Chief (AOC-in-C)…